Probiotics may reduce risk of VAP in ICU patients

06/17/2010 | Science Blog

Daily probiotic therapy halved the risk of ventilator-associated pneumonia in a select group of patients in the intensive care unit, U.S. researchers found. The study, which used twice-daily doses of Lactobacillus rhamnosus, also showed that the treatment reduced the amount of antibiotics needed after almost five years.

View Full Article in:

Science Blog

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC